Cargando…
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021312/ https://www.ncbi.nlm.nih.gov/pubmed/35443743 http://dx.doi.org/10.1038/s41408-022-00667-9 |
| _version_ | 1784689785904824320 |
|---|---|
| author | Adnan Awad, Shady Brück, Oscar Shanmuganathan, Naranie Jarvinen, Timo Lähteenmäki, Hanna Klievink, Jay Ibrahim, Hazem Kytölä, Soili Koskenvesa, Perttu Hughes, Timothy P. Branford, Susan Kankainen, Matti Mustjoki, Satu |
| author_facet | Adnan Awad, Shady Brück, Oscar Shanmuganathan, Naranie Jarvinen, Timo Lähteenmäki, Hanna Klievink, Jay Ibrahim, Hazem Kytölä, Soili Koskenvesa, Perttu Hughes, Timothy P. Branford, Susan Kankainen, Matti Mustjoki, Satu |
| author_sort | Adnan Awad, Shady |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9021312 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90213122022-04-28 Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation Adnan Awad, Shady Brück, Oscar Shanmuganathan, Naranie Jarvinen, Timo Lähteenmäki, Hanna Klievink, Jay Ibrahim, Hazem Kytölä, Soili Koskenvesa, Perttu Hughes, Timothy P. Branford, Susan Kankainen, Matti Mustjoki, Satu Blood Cancer J Correspondence Nature Publishing Group UK 2022-04-20 /pmc/articles/PMC9021312/ /pubmed/35443743 http://dx.doi.org/10.1038/s41408-022-00667-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Adnan Awad, Shady Brück, Oscar Shanmuganathan, Naranie Jarvinen, Timo Lähteenmäki, Hanna Klievink, Jay Ibrahim, Hazem Kytölä, Soili Koskenvesa, Perttu Hughes, Timothy P. Branford, Susan Kankainen, Matti Mustjoki, Satu Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title | Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title_full | Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title_fullStr | Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title_full_unstemmed | Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title_short | Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| title_sort | epigenetic modifier gene mutations in chronic myeloid leukemia (cml) at diagnosis are associated with risk of relapse upon treatment discontinuation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021312/ https://www.ncbi.nlm.nih.gov/pubmed/35443743 http://dx.doi.org/10.1038/s41408-022-00667-9 |
| work_keys_str_mv | AT adnanawadshady epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT bruckoscar epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT shanmuganathannaranie epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT jarvinentimo epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT lahteenmakihanna epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT klievinkjay epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT ibrahimhazem epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT kytolasoili epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT koskenvesaperttu epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT hughestimothyp epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT branfordsusan epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT kankainenmatti epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation AT mustjokisatu epigeneticmodifiergenemutationsinchronicmyeloidleukemiacmlatdiagnosisareassociatedwithriskofrelapseupontreatmentdiscontinuation |